Correlation Between Oasmia Pharmaceutical and Cardiol Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oasmia Pharmaceutical and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oasmia Pharmaceutical and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oasmia Pharmaceutical AB and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Oasmia Pharmaceutical and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oasmia Pharmaceutical with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oasmia Pharmaceutical and Cardiol Therapeutics.

Diversification Opportunities for Oasmia Pharmaceutical and Cardiol Therapeutics

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Oasmia and Cardiol is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Oasmia Pharmaceutical AB and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Oasmia Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oasmia Pharmaceutical AB are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Oasmia Pharmaceutical i.e., Oasmia Pharmaceutical and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between Oasmia Pharmaceutical and Cardiol Therapeutics

If you would invest  6.00  in Oasmia Pharmaceutical AB on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Oasmia Pharmaceutical AB or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy4.76%
ValuesDaily Returns

Oasmia Pharmaceutical AB  vs.  Cardiol Therapeutics Class

 Performance 
       Timeline  
Oasmia Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oasmia Pharmaceutical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Oasmia Pharmaceutical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Cardiol Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Oasmia Pharmaceutical and Cardiol Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oasmia Pharmaceutical and Cardiol Therapeutics

The main advantage of trading using opposite Oasmia Pharmaceutical and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oasmia Pharmaceutical position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.
The idea behind Oasmia Pharmaceutical AB and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes